{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T15:58:50Z","timestamp":1712591930313},"reference-count":48,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.vaccine.2010.06.112","type":"journal-article","created":{"date-parts":[[2010,7,24]],"date-time":"2010-07-24T10:49:03Z","timestamp":1279968543000},"page":"6305-6313","source":"Crossref","is-referenced-by-count":8,"title":["The effects of preexisting immunity to influenza on responses to influenza vectors in mice"],"prefix":"10.1016","volume":"28","author":[{"given":"William A.","family":"Langley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konrad C.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu-Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh R.","family":"Talekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Summer E.","family":"Galloway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Steinhauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"November (19)","key":"10.1016\/j.vaccine.2010.06.112_bib1","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of humoral immunity to common viral and vaccine antigens","volume":"357","author":"Amanna","year":"2007","journal-title":"N Engl J Med"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.06.112_bib2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nrmicro2240","article-title":"Viruses as vaccine vectors for infectious diseases and cancer","volume":"8","author":"Draper","year":"2010","journal-title":"Nat Rev Microbiol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.06.112_bib3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4049\/jimmunol.174.1.449","article-title":"Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers","volume":"174","author":"Vuola","year":"2005","journal-title":"J Immunol"},{"issue":"March (13)","key":"10.1016\/j.vaccine.2010.06.112_bib4","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1073\/pnas.0406381102","article-title":"Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara","volume":"102","author":"Webster","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2010.06.112_bib5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0092-8674(94)90336-0","article-title":"MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation","volume":"76","author":"Germain","year":"1994","journal-title":"Cell"},{"issue":"September (18)","key":"10.1016\/j.vaccine.2010.06.112_bib6","doi-asserted-by":"crossref","first-page":"9584","DOI":"10.1128\/JVI.00821-09","article-title":"Protective efficacy of a single immunization of a chimeric adenovirus vector-based vaccine against simian immunodeficiency virus challenge in rhesus monkeys","volume":"83","author":"Barouch","year":"2009","journal-title":"J Virol"},{"issue":"July (33)","key":"10.1016\/j.vaccine.2010.06.112_bib7","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1016\/j.vaccine.2009.05.044","article-title":"Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus","volume":"27","author":"Guthrie","year":"2009","journal-title":"Vaccine"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2010.06.112_bib8","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1128\/JVI.02242-07","article-title":"Expansion and exhaustion of T-cell responses during mutational escape from long-term viral control in two DNA\/modified vaccinia virus Ankara-vaccinated and simian-human immunodeficiency virus SHIV-89.6P-challenged macaques","volume":"82","author":"Sadagopal","year":"2008","journal-title":"J Virol"},{"issue":"September (2)","key":"10.1016\/j.vaccine.2010.06.112_bib9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.virol.2006.05.010","article-title":"Rabies virus glycoprotein as a carrier for anthrax protective antigen","volume":"353","author":"Smith","year":"2006","journal-title":"Virology"},{"issue":"August (36)","key":"10.1016\/j.vaccine.2010.06.112_bib10","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1016\/j.vaccine.2009.05.096","article-title":"A chimeric measles virus with canine distemper envelope protects ferrets from lethal distemper challenge","volume":"27","author":"Rouxel","year":"2009","journal-title":"Vaccine"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2010.06.112_bib11","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0198-8859(00)00170-1","article-title":"Comparison of in vitro immunostimulatory potential of live and inactivated influenza viruses","volume":"61","author":"Blazevic","year":"2000","journal-title":"Hum Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.06.112_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0300-9475.2004.01382.x","article-title":"Influenza virus: immunity and vaccination strategies, Comparison of the immune response to inactivated and live, attenuated influenza vaccines","volume":"59","author":"Cox","year":"2004","journal-title":"Scand J Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.06.112_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3201\/eid1201.051237","article-title":"Cell-mediated protection in influenza infection","volume":"12","author":"Thomas","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"August (11)","key":"10.1016\/j.vaccine.2010.06.112_bib14","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0264-410X(94)90334-4","article-title":"An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination","volume":"12","author":"Cox","year":"1994","journal-title":"Vaccine"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2010.06.112_bib15","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/01.inf.0000237797.14283.cf","article-title":"Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma","volume":"25","author":"Fleming","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2010.06.112_bib16","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.4049\/jimmunol.127.6.2588","article-title":"Specific anti-influenza virus antibody production in vitro by human peripheral blood mononuclear cells","volume":"127","author":"Yarchoan","year":"1981","journal-title":"J Immunol"},{"issue":"August (16)","key":"10.1016\/j.vaccine.2010.06.112_bib17","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","article-title":"Generation of influenza A viruses entirely from cloned cDNAs","volume":"96","author":"Neumann","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2010.06.112_bib18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev.bi.56.070187.002053","article-title":"The structure and function of the hemagglutinin membrane glycoprotein of influenza virus","volume":"56","author":"Wiley","year":"1987","journal-title":"Annu Rev Biochem"},{"issue":"7","key":"10.1016\/j.vaccine.2010.06.112_bib19","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2174\/092986609788681715","article-title":"Composition and functions of the influenza fusion peptide","volume":"16","author":"Cross","year":"2009","journal-title":"Protein Pept Lett"},{"key":"10.1016\/j.vaccine.2010.06.112_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1146\/annurev.genet.36.052402.152757","article-title":"Genetics of influenza viruses","volume":"36","author":"Steinhauer","year":"2002","journal-title":"Annu Rev Genet"},{"issue":"January (5796)","key":"10.1016\/j.vaccine.2010.06.112_bib21","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/289366a0","article-title":"Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution","volume":"289","author":"Wilson","year":"1981","journal-title":"Nature"},{"issue":"August (15)","key":"10.1016\/j.vaccine.2010.06.112_bib22","doi-asserted-by":"crossref","first-page":"10003","DOI":"10.1128\/JVI.79.15.10003-10012.2005","article-title":"Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity","volume":"79","author":"Li","year":"2005","journal-title":"J Virol"},{"issue":"September (18)","key":"10.1016\/j.vaccine.2010.06.112_bib23","doi-asserted-by":"crossref","first-page":"9624","DOI":"10.1128\/JVI.78.18.9624-9632.2004","article-title":"Intranasal immunization with inactivated influenza virus enhances immune responses to coadministered simian-human immunodeficiency virus-like particle antigens","volume":"78","author":"Kang","year":"2004","journal-title":"J Virol"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2010.06.112_bib25","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1128\/JVI.79.5.2814-2822.2005","article-title":"Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls","volume":"79","author":"Fouchier","year":"2005","journal-title":"J Virol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.06.112_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.immuni.2006.01.007","article-title":"What can we learn from reconstructing the extinct 1918 pandemic influenza virus?","volume":"24","author":"Palese","year":"2006","journal-title":"Immunity"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2010.06.112_bib27","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1086\/597073","article-title":"Transmission of influenza virus via aerosols and fomites in the guinea pig model","volume":"199","author":"Mubareka","year":"2009","journal-title":"J Infect Dis"},{"issue":"October (1)","key":"10.1016\/j.vaccine.2010.06.112_bib28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virol.2006.06.024","article-title":"Influenza A virus infection of primary differentiated airway epithelial cell cultures derived from Syrian golden hamsters","volume":"354","author":"Newby","year":"2006","journal-title":"Virology"},{"issue":"May (2)","key":"10.1016\/j.vaccine.2010.06.112_bib29","doi-asserted-by":"crossref","first-page":"A110","DOI":"10.1016\/j.antiviral.2008.12.014","article-title":"Animal models for the study of influenza pathogenesis and therapy","volume":"82","author":"Barnard","year":"2009","journal-title":"Antiviral Res"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.06.112_bib30","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1128\/JVI.68.6.3486-3490.1994","article-title":"Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized by cytotoxic T lymphocytes","volume":"68","author":"Castrucci","year":"1994","journal-title":"J Virol"},{"issue":"November (5)","key":"10.1016\/j.vaccine.2010.06.112_bib31","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1086\/314445","article-title":"Chimeric influenza virus replicating predominantly in the murine upper respiratory tract induces local immune responses against human immunodeficiency virus type 1 in the genital tract","volume":"178","author":"Ferko","year":"1998","journal-title":"J Infect Dis"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2010.06.112_bib32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/biol.1995.0028","article-title":"Influenza virus vectors","volume":"23","author":"Garcia-Sastre","year":"1995","journal-title":"Biologicals"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2010.06.112_bib33","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1128\/IAI.66.8.3990-3994.1998","article-title":"A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P. aeruginosa in a murine model of chronic pulmonary infection","volume":"66","author":"Staczek","year":"1998","journal-title":"Infect Immun"},{"issue":"November","key":"10.1016\/j.vaccine.2010.06.112_bib34","article-title":"Immunization with live-attenuated influenza viruses expressing altered NS1 proteins results in potent and protective memory CD8+ T cells responses","author":"Mueller","year":"2009","journal-title":"J Virol"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2010.06.112_bib35","first-page":"103","article-title":"Inactivation of poliovirus with beta-propiolactone","volume":"14","author":"Jiang","year":"1986","journal-title":"J Biol Stand"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.06.112_bib36","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1128\/JVI.73.4.3080-3086.1999","article-title":"T cells contribute to disease severity during coxsackievirus B4 infection","volume":"73","author":"Ramsingh","year":"1999","journal-title":"J Virol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.06.112_bib37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1074-7613(00)80470-7","article-title":"Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection","volume":"8","author":"Murali-Krishna","year":"1998","journal-title":"Immunity"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2010.06.112_bib38","doi-asserted-by":"crossref","first-page":"518","DOI":"10.7326\/0003-4819-123-7-199510010-00008","article-title":"The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature","volume":"123","author":"Gross","year":"1995","journal-title":"Ann Intern Med"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2010.06.112_bib39","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1128\/JVI.74.8.3486-3493.2000","article-title":"A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge","volume":"74","author":"Belz","year":"2000","journal-title":"J Virol"},{"issue":"September (1)","key":"10.1016\/j.vaccine.2010.06.112_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/viro.1998.9330","article-title":"Transfectant influenza A viruses are effective recombinant immunogens in the treatment of experimental cancer","volume":"249","author":"Restifo","year":"1998","journal-title":"Virology"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.06.112_bib41","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1073\/pnas.0609330104","article-title":"Ab and T cell epitopes of influenza A virus, knowledge and opportunities","volume":"104","author":"Bui","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"October (45)","key":"10.1016\/j.vaccine.2010.06.112_bib42","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1016\/j.vaccine.2009.01.016","article-title":"Influenza virus CTL epitopes, remarkably conserved and remarkably variable","volume":"27","author":"Rimmelzwaan","year":"2009","journal-title":"Vaccine"},{"issue":"September (17)","key":"10.1016\/j.vaccine.2010.06.112_bib43","doi-asserted-by":"crossref","first-page":"11239","DOI":"10.1128\/JVI.79.17.11239-11246.2005","article-title":"Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes","volume":"79","author":"Berkhoff","year":"2005","journal-title":"J Virol"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2010.06.112_bib44","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1128\/iai.29.2.654-662.1980","article-title":"Outcome of influenza infection: effect of site of initial infection and heterotypic immunity","volume":"29","author":"Yetter","year":"1980","journal-title":"Infect Immun"},{"issue":"January (4)","key":"10.1016\/j.vaccine.2010.06.112_bib45","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.vaccine.2006.08.036","article-title":"Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice","volume":"25","author":"Kreijtz","year":"2007","journal-title":"Vaccine"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2010.06.112_bib46","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1084\/jem.186.12.2063","article-title":"Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice","volume":"186","author":"Graham","year":"1997","journal-title":"J Exp Med"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2010.06.112_bib47","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1128\/JVI.02694-07","article-title":"Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus","volume":"82","author":"Kreijtz","year":"2008","journal-title":"J Virol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2010.06.112_bib48","doi-asserted-by":"crossref","first-page":"8682","DOI":"10.1128\/JVI.72.11.8682-8689.1998","article-title":"Human cytotoxic T-lymphocyte repertoire to influenza A viruses","volume":"72","author":"Jameson","year":"1998","journal-title":"J Virol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.06.112_bib49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/498980","article-title":"Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature","volume":"193","author":"Epstein","year":"2006","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10009539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10009539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T08:55:10Z","timestamp":1685696110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10009539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":48,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0264410X10009539"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.06.112","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}